2-149575863-C-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_015702.3(MMADHC):c.479-22G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.76 in 1,553,354 control chromosomes in the GnomAD database, including 458,468 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.65 ( 35624 hom., cov: 33)
Exomes 𝑓: 0.77 ( 422844 hom. )
Consequence
MMADHC
NM_015702.3 intron
NM_015702.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.14
Publications
8 publications found
Genes affected
MMADHC (HGNC:25221): (metabolism of cobalamin associated D) This gene encodes a mitochondrial protein that is involved in an early step of vitamin B12 metabolism. Vitamin B12 (cobalamin) is essential for normal development and survival in humans. Mutations in this gene cause methylmalonic aciduria and homocystinuria type cblD (MMADHC), a disorder of cobalamin metabolism that is characterized by decreased levels of the coenzymes adenosylcobalamin and methylcobalamin. Pseudogenes have been identified on chromosomes 11 and X.[provided by RefSeq, Nov 2008]
MMADHC Gene-Disease associations (from GenCC):
- inborn disorder of cobalamin metabolism and transportInheritance: AR Classification: DEFINITIVE Submitted by: Ambry Genetics, ClinGen
- methylmalonic aciduria and homocystinuria type cblDInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 2-149575863-C-G is Benign according to our data. Variant chr2-149575863-C-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 260678.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.838 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MMADHC | NM_015702.3 | c.479-22G>C | intron_variant | Intron 5 of 7 | ENST00000303319.10 | NP_056517.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MMADHC | ENST00000303319.10 | c.479-22G>C | intron_variant | Intron 5 of 7 | 1 | NM_015702.3 | ENSP00000301920.5 | |||
| MMADHC | ENST00000422782.2 | c.479-22G>C | intron_variant | Intron 5 of 8 | 5 | ENSP00000408331.2 | ||||
| MMADHC | ENST00000428879.5 | c.479-22G>C | intron_variant | Intron 4 of 6 | 2 | ENSP00000389060.1 |
Frequencies
GnomAD3 genomes AF: 0.649 AC: 98502AN: 151850Hom.: 35618 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
98502
AN:
151850
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.751 AC: 168708AN: 224514 AF XY: 0.759 show subpopulations
GnomAD2 exomes
AF:
AC:
168708
AN:
224514
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.772 AC: 1081754AN: 1401388Hom.: 422844 Cov.: 24 AF XY: 0.773 AC XY: 539225AN XY: 697548 show subpopulations
GnomAD4 exome
AF:
AC:
1081754
AN:
1401388
Hom.:
Cov.:
24
AF XY:
AC XY:
539225
AN XY:
697548
show subpopulations
African (AFR)
AF:
AC:
8981
AN:
32322
American (AMR)
AF:
AC:
29287
AN:
42014
Ashkenazi Jewish (ASJ)
AF:
AC:
19982
AN:
24956
East Asian (EAS)
AF:
AC:
34004
AN:
38958
South Asian (SAS)
AF:
AC:
61973
AN:
81564
European-Finnish (FIN)
AF:
AC:
44028
AN:
51978
Middle Eastern (MID)
AF:
AC:
4170
AN:
5568
European-Non Finnish (NFE)
AF:
AC:
835366
AN:
1065898
Other (OTH)
AF:
AC:
43963
AN:
58130
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
9515
19030
28546
38061
47576
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
19628
39256
58884
78512
98140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.648 AC: 98521AN: 151966Hom.: 35624 Cov.: 33 AF XY: 0.653 AC XY: 48479AN XY: 74274 show subpopulations
GnomAD4 genome
AF:
AC:
98521
AN:
151966
Hom.:
Cov.:
33
AF XY:
AC XY:
48479
AN XY:
74274
show subpopulations
African (AFR)
AF:
AC:
12500
AN:
41368
American (AMR)
AF:
AC:
10053
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
AC:
2781
AN:
3470
East Asian (EAS)
AF:
AC:
4432
AN:
5160
South Asian (SAS)
AF:
AC:
3695
AN:
4818
European-Finnish (FIN)
AF:
AC:
9008
AN:
10594
Middle Eastern (MID)
AF:
AC:
211
AN:
290
European-Non Finnish (NFE)
AF:
AC:
53734
AN:
67972
Other (OTH)
AF:
AC:
1421
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1446
2892
4338
5784
7230
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
778
1556
2334
3112
3890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2711
AN:
3438
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Jun 29, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Methylmalonic aciduria and homocystinuria type cblD Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.